This study compares four active-learning virtual screening workflows and suggests that combining active learning with SILCS provides a computationally efficient, membrane-aware approach for screening compounds at transmembrane binding sites.
Abstract
The rapid expansion of large chemical libraries has created a need for virtual screening workflows that are both efficient and accurate. Active learning (AL) offers a scalable strategy by iteratively training surrogate models to prioritize promising compounds and reduce the number of required docking calculations. However, direct benchmarking of active-learning protocols across docking engines remains limited. In this study, we ask whether docking scores generated by different docking engines affect AL performance and what factors underlie these differences. To do so, we compare four active-learning virtual screening workflows, Vina-MolPAL, Glide-MolPAL, SILCS-MolPAL, and Schrödinger’s active-learning Glide, across multiple protein targets and library sizes. Performance was assessed by recovery of top-scoring molecules according to each workflow’s respective docking engine, score-prediction accuracy, chemical diversity, and computational cost. Vina-MolPAL achieved the highest top-1% recovery at a 1% batch size, whereas SILCS-MolPAL achieved comparable recovery at a larger batch size. Latent-embedding analyses suggest that the docking-score landscape strongly influences active-learning performance. In addition, combining active learning with SILCS provides a computationally efficient, membrane-aware approach for screening compounds at transmembrane binding sites.
MolDockLab addresses the challenge of structure-based virtual screening with an automated, data-driven framework that optimizes SBVS workflows for a protein target, balancing predictive performance and computational efficiency.
Hamza Agha, Y. Ibrahim, Michael Backenköhler et al.· npj Drug Discovery· 0 citations
This study employed an integrated ligand-based virtual screening pipeline to identify potential CASP4 inhibitors from the DrugBank database, leveraging docking-score prioritization, SMILES-derived ChemBERTa embeddings, and key physicochemical descriptors to systematically prioritize repurposed DrugBank compounds for CA...
Mubashir Hassan, S. Bhatti, Muhammad Yasir et al.· Journal of Chemical Informat...· 0 citations
A comprehensive review of how Artificial Intelligence and Machine Learning are redefining this landscape across three critical dimensions outlines the transition toward end‐to‐end, adaptive discovery systems that ensure computational hits are biologically potent, structurally optimized, and synthetically accessible.
Yi-Fei Wang, Nupur Bansal, Shiyun Wa et al.· WIREs Computational Molecula...· 0 citations
Overall, this end-to-end workflow efficiently compresses large libraries into a confirmed micromolar CXCR4 hit while lowering computational and infrastructure barriers for early-stage discovery.
It is elucidated that HY-18,623 achieves high-affinity binding through persistent hydrogen bonds with hinge residues Val96 (CDK4) and Val101 (CDK6) and Val101 (CDK6) as a promising lead candidate for further therapeutic development in oncology.
Yu-Xin Wang, Lin-Xia Fang, Quan-Fang Liu et al.· Molecular diversity· 0 citations
This work introduces SB2025, a calculation-ready set of 1,244 protein-ligand complexes derived from the PDB, curated using literature-based ligand protonation states, and freely available in DOCK6, AutoDock Vina, and AutoDock 4 (AD4) formats.
Carissa P. Corbo, Scott Laverty, Robert C. Rizzo· Journal of Chemical Informat...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.